Vera Therapeutics is trading at $29.78, up 5.23% in pre-market, with no clear company-specific announcement identified for October 27, 2026.

  • The company’s latest reported major news was positive ORIGIN 3 trial results, announced October 22.
  • Supplied major-index moves are modest and do not establish a broader-market explanation for the gain; no reliable pre-market volume information was found.